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The Brain Natriuretic Peptide; brain natriuretic peptide 
(BNP) and its inactive precursor N-terminal pro-BNP, are 
well-established risk markers in various acute and chronic 
cardiac conditions. However, their value as preoperative risk 
markers is unclear. BNP is secreted by cardiac myocytes in 
response to mechanical stretching caused by both pressure 
and volume overload. Myocardial damage or ventricular dys-
function (both systolic and diastolic) raises the plasma level 
of BNP. Even a transient myocardial ischemia owing to the de-
mand and supply imbalance produces measurable change in 
plasma BNP levels. 
The perioperative period can result in a period of critical st-
ress. Factors associated with surgery and anesthesia such as 
trauma, bleeding, intubation, hypoxia, hypothermia, pain and 
medications induce intense inflammation, hypercoagulabili-
ty and sympathetic activation. All these factors trigger acute 
cardiac ischemia, arrhythmia and ventricular decompensa-
tion, which are associated with perioperative elevation of tro-
ponin, C-reactive protein and BNP. Interest in BNP as a preop-
erative risk marker has increased because the currently used 
preoperative clinical cardiac risk indices have only modest pre-
dictive power. It is inevitable since many surgical patients have 
underlying diseases, such as arthritis, cancer and diabetes mel-
litus, which limit physical activities to exhibit symptoms of ex-
isting cardiac disease. Although stress tests using imaging 
modalities can be recruited, BNP is a fair and easy alternative 
to get additive prognostic information. Recent meta-analyses 
of observational studies demonstrated that preoperative BNP 
elevation is associated with postoperative major adverse car-
diovascular events (cardiac death, nonfatal myocardial infarc-
tion and arrhythmias with hemodynamic compromise).
1)2) 
Current practice guidelines from the European Society of Car-
diology recommend the preoperative BNP measurement for 
prognostication in high-risk patients (class of recommendation 
IIa, level of evidence B).
3)
In this issue, Kim and Park et al.
4) present their study about 
the utility of BNP to predict short-term postoperative cardio-
vascular events in patients without history of cardiovascular 
disease undergoing major non-cardiac surgery. According to 
their definition of cardiovascular events, eight (4.5%, no death 
occurred) of 163 patients experienced cardiovascular events in 
the perioperative period. Cardiovascular events were defined 
at low threshold, possibly because their study population 
had relatively low risk profiles. The preoperative BNP levels 
were significantly higher in patients who underwent cardio-
vascular events compared with those who did not (p=0.009). 
With the cut-off value of >64.5 pg/mL, preoperative BNP pre-
dicted the perioperative cardiovascular events with an area un-
der the receiver operator characteristic curve of 0.76 (95% con-
fidence interval 0.63-0.89, p=0.014). As BNP is a continuous 
variable and changes quantitatively in a wide range of diseases, 
the higher level implies greater disease burden. From a clini-
cal point of view, BNP could be used for additional prognos-
tic information in patients with intermediate risk such as ad-
vanced age, anticipating major surgery or chronic illness. It is 
not clear which ranges of preoperative BNP levels are selected 
for special attention to intensify cardiac tests and periopera-
tive management. The effect of BNP-guided intervention be-
fore surgery also remains to be elucidated. 
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In conclusion, the work by Kim et al.
4) reminds us that even 
in a low-risk population, higher BNP levels are associated 
with more postoperative cardiovascular events. Further re-
search is needed to unite BNP into a comprehensive preop-
erative risk model which is applicable in various clinical situ-
ations. 
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